132 Annual Meeting Logo - Go to APHA Meeting Page  
APHA Logo - Go to APHA Home Page
Session: Fighting the Good Fight: Opioids and Buprenorphine
3310.0: Monday, November 8, 2004: 4:30 PM-6:00 PM
Fighting the Good Fight: Opioids and Buprenorphine
Learning Objectives: see individual abstracts
Moderator(s):Marilyn C. Daley, PhD
4:30 PMMethadone dosage and retention: An examination of the 60mg/day threshold
Thomas M. Brady, PhD, Sameena Salvucci, PhD, Lev S. Sverdlov, MD, PhD, Alisa Male, MA, Hannah Kyeyune, MS, Emmanuel Sikali, MS
4:48 PMIntroduction to buprenorphine and office-based opioid addiction therapy under the new paradigm established by the Drug Addiction Treatment Act of 2000
Wayne Brandes, DO
5:06 PMIntegrating methadone and buprenorphine treatment for opiate addiction into physician office settings: The San Francisco OBOT pilot program
Alice A. Gleghorn, PhD, Richard Fine, MD, David Hersh, MD, Brigitte Lank, PhD, Stephanie Marsan, MD, Jim Westphal, MD
5:24 PMAttitudes toward buprenorphine in substance abuse treatment programs  [ Recorded presentation ]
Marilyn C. Daley, PhD, Dennis McCarty, PhD, Cindy Parks Thomas, PA, PhD, Traci Rieckmann, PhD
5:42 PMExpanding treatment options for opioid dependence: Physician acceptance of buprenorphine treatment  [ Recorded presentation ]
Caroline C. McLeod, PhD, Arlene Stanton, PhD, Wendy Kissin, PhD, L. Joseph Sonnefeld, MA, James W. Luckey, PhD
See individual abstracts for presenting author's disclosure statement and author's information.
Organized by:Alcohol, Tobacco, and Other Drugs
CE Credits:CME, Health Education (CHES), Nursing

The 132nd Annual Meeting (November 6-10, 2004) of APHA